Evidence map›Paper›PMID 40297448›Full record

ArticlemedRxiv : the preprint server for health sciences2025

REASONING BEYOND ACCURACY: EXPERT EVALUATION OF LARGE LANGUAGE MODELS IN DIAGNOSTIC PATHOLOGY.

Asim Waqas, Asma Khan, Zarifa Gahramanli Ozturk, Daryoush Saeed-Vafa, Weishen Chen, Jasreman Dhillon, Andrey Bychkov, Marilyn M Bui, Ehsan Ullah, Farah Khalil and 7 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Asim WaqasDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.ORCID 0000-0002-6834-4710
Asma KhanArmed Forces Institute of Pathology, Rawalpindi, Pakistan.ORCID 0009-0002-4694-4114
Zarifa Gahramanli OzturkClinical Science Lab, H. Lee Moffitt Cancer Center & Research Institute.ORCID 0000-0002-9353-1542
Daryoush Saeed-VafaDepartment of Pathology, H. Lee Moffitt Cancer Center & Research Institute.ORCID 0000-0001-5010-0964
Weishen ChenDepartment of Dermatology & Cutaneous Surgery, University of South Florida, Tampa, FL.ORCID 0000-0001-9040-4786
Jasreman DhillonDepartment of Anatomic Pathology, H. Lee Moffitt Cancer Center & Research Institute.ORCID 0000-0001-6785-3487
Andrey BychkovDepartment of Pathology, Kameda Medical Center, Kamogawa City, Chiba Prefecture, Japan.ORCID 0000-0002-4203-5696
Marilyn M BuiDepartment of Pathology, H. Lee Moffitt Cancer Center & Research Institute.ORCID 0000-0003-4963-2255
Ehsan UllahDepartment of Surgery, Health New Zealand, Counties Manukau, Auckland, New Zealand.ORCID 0000-0001-6470-3731
Farah KhalilDepartment of Pathology, H. Lee Moffitt Cancer Center & Research Institute.ORCID 0000-0002-2366-7209
Vaibhav ChumbalkarDepartment of Pathology, H. Lee Moffitt Cancer Center & Research Institute.ORCID 0000-0002-7528-7611
Zena JameelDepartment of Pathology, H. Lee Moffitt Cancer Center & Research Institute.ORCID 0000-0003-3057-0066
Humberto Trejo BittarDepartment of Pathology, H. Lee Moffitt Cancer Center & Research Institute.ORCID 0000-0003-2701-6531
Rajendra S SinghDermatopathology and Digital Pathology, Summit Health, Berkley Heights, NJ.ORCID 0000-0003-4420-5561
Anil V ParwaniDepartment of Pathology, The Ohio State University, Columbus, Ohio.ORCID 0009-0007-7224-6682
Matthew B SchabathDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute.ORCID 0000-0003-3241-3216
Ghulam RasoolDepartment of Machine Learning, H. Lee Moffitt Cancer Center & Research Institute.ORCID 0000-0001-8551-0090

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI John L. Cleveland · 1998 to 2026
$93.5M
Quantitative Imaging Clinical Validation Center at Moffitt Cancer CenterU01CA200464 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI JOHN J HEINE, Matthew B. Schabath · 2016 to 2026
$9.2M
NCI NIH HHS P30 CA076292NCI NIH HHS U01 CA200464
6 · The paper itself

Abstract

Background: Diagnostic pathology depends on complex, structured reasoning to interpret clinical, histologic, and molecular data. Replicating this cognitive process algorithmically remains a significant challenge. As large language models (LLMs) gain traction in medicine, it is critical to determine whether they have clinical utility by providing reasoning in highly specialized domains such as pathology. Methods: We evaluated the performance of four reasoning LLMs (OpenAI o1, OpenAI o3-mini, Gemini 2.0 Flash Thinking Experimental, and DeepSeek-R1 671B) on 15 board-style open-ended pathology questions. Responses were independently reviewed by 11 pathologists using a structured framework that assessed language quality (accuracy, relevance, coherence, depth, and conciseness) and seven diagnostic reasoning strategies. Scores were normalized and aggregated for analysis. We also evaluated inter-observer agreement to assess scoring consistency. Model comparisons were conducted using one-way ANOVA and Tukey's Honestly Significant Difference (HSD) test. Results: Gemini and DeepSeek significantly outperformed OpenAI o1 and OpenAI o3-mini in overall reasoning quality (p < 0.05), particularly in analytical depth and coherence. While all models achieved comparable accuracy, only Gemini and DeepSeek consistently applied expert-like reasoning strategies, including algorithmic, inductive, and Bayesian approaches. Performance varied by reasoning type: models performed best in algorithmic and deductive reasoning and poorest in heuristic and pattern recognition. Inter-observer agreement was highest for Gemini (p < 0.05), indicating greater consistency and interpretability. Models with more in-depth reasoning (Gemini and DeepSeek) were generally less concise. Conclusion: Advanced LLMs such as Gemini and DeepSeek can approximate aspects of expert-level diagnostic reasoning in pathology, particularly in algorithmic and structured approaches. However, limitations persist in contextual reasoning, heuristic decision-making, and consistency across questions. Addressing these gaps, along with trade-offs between depth and conciseness, will be essential for the safe and effective integration of AI tools into clinical pathology workflows.

Indexed as

AI EvaluationClinical ReasoningGenerative AIPathologyReasoning Large Language Models

Identifiers

PMID40297448
PMCPMC12036407

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.